Kura Oncology, Inc.

KURA Shareholders Vote on Equity Plan Increases and Board Seats

# 🧾 What This Document Is This is Kura Oncology's **Definitive Proxy Statement (DEF 14A)**. Think of it as the official "menu" and instruction manual for the company's upcoming annual shareholder meeting. It details what shareholders will vote on, provides background on the people running the compa